These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment. Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134 [TBL] [Abstract][Full Text] [Related]
4. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition. Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease. Pereira JB; Hall S; Jalakas M; Grothe MJ; Strandberg O; Stomrud E; Westman E; van Westen D; Hansson O Neurobiol Dis; 2020 Jun; 139():104831. PubMed ID: 32145376 [TBL] [Abstract][Full Text] [Related]
7. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835 [TBL] [Abstract][Full Text] [Related]
8. Cortical thinning across Parkinson's disease stages and clinical correlates. Wilson H; Niccolini F; Pellicano C; Politis M J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518 [TBL] [Abstract][Full Text] [Related]
14. Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment. Zhou C; Guan XJ; Guo T; Zeng QL; Gao T; Huang PY; Xuan M; Gu QQ; Xu XJ; Zhang MM CNS Neurosci Ther; 2020 Jan; 26(1):117-125. PubMed ID: 31278861 [TBL] [Abstract][Full Text] [Related]
15. Regional volumetric change in Parkinson's disease with cognitive decline. Gee M; Dukart J; Draganski B; Wayne Martin WR; Emery D; Camicioli R J Neurol Sci; 2017 Feb; 373():88-94. PubMed ID: 28131236 [TBL] [Abstract][Full Text] [Related]
16. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up. Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765 [TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Hobson P; Meara J Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease. Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368 [TBL] [Abstract][Full Text] [Related]
19. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873 [TBL] [Abstract][Full Text] [Related]
20. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease. Chung SJ; Park YH; Yoo HS; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH Neurobiol Aging; 2019 Jun; 78():168-177. PubMed ID: 30947112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]